missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Invitrogen™ CD99 Polyclonal Antibody
Goat Polyclonal Antibody
Marca: Invitrogen™ PA547551
Este artículo no se puede devolver.
Vea la política de devoluciones
Descripción
In direct ELISAs, less than 1% cross-reactivity with recombinant mouse (rm) PILR- alpha and rmPILR- beta is observed. Reconstitute at 0.2 mg/mL in sterile PBS.
CD99 (E2, MIC2) is a transmembrane glycoprotein that is involved in regulation of T cell addhesive properties and programmed cell death distinct from typical apoptosis course. CD99 roles are specific to certain stages of T cell differentiation such as corticothymocytes. CD99R isoform expression is restricted in the haematopoietic system to T, NK and myeloid cells.
Especificaciones
| CD99 | |
| Polyclonal | |
| Unconjugated | |
| CD99 | |
| 1110061M03Rik; 12E7; 2410026K10Rik; antigen identified by monoclonal 12E7, Y homolog; antigen identified by monoclonal antibodies 12E7, F21 and O13; Cd99; CD99 antigen; CD99 molecule; cell surface antigen 12E7; cell surface antigen HBA-71; cell surface antigen O13; D4; E2 antigen; HBA71; MIC2; MIC2 (monoclonal antibody 12E7); MIC2X; MIC2Y; MSK5X; paired immunoglobin-like type 2 receptor-ligand; pilr-1; Pilrl; PILR-L; Protein MIC2; surface antigen MIC2; T-cell surface glycoprotein E2 | |
| Goat | |
| Antigen affinity chromatography | |
| RUO | |
| 673094 | |
| -20°C, Avoid Freeze/Thaw Cycles | |
| Lyophilized |
| Flow Cytometry, Western Blot | |
| 0.2 mg/mL | |
| PBS with 5% trehalose and No Preservative | |
| Q8VCN6 | |
| CD99 | |
| Mouse myeloma cell line NS0-derived recombinant mouse CD99 Gly25-Leu138. | |
| 100 μg | |
| Primary | |
| Mouse | |
| Antibody | |
| IgG |
Título del producto
Al hacer clic en Enviar, acepta que Fisher Scientific se ponga en contacto con usted en relación con los comentarios que ha proporcionado en este formulario. No compartiremos su información para ningún otro fin. Toda la información de contacto proporcionada se mantendrá de acuerdo con nuestra Política de Privacidad. Política de privacidad.
¿Detecta una oportunidad de mejora?